These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Safety Profile and Immunologic Responses of a Novel Vaccine Against Shigella sonnei Administered Intramuscularly, Intradermally and Intranasally: Results From Two Parallel Randomized Phase 1 Clinical Studies in Healthy Adult Volunteers in Europe. Launay O; Lewis DJM; Anemona A; Loulergue P; Leahy J; Sciré AS; Maugard A; Marchetti E; Zancan S; Huo Z; Rondini S; Marhaba R; Finco O; Martin LB; Auerbach J; Cohen D; Saul A; Gerke C; Podda A EBioMedicine; 2017 Aug; 22():164-172. PubMed ID: 28735965 [TBL] [Abstract][Full Text] [Related]
5. Development of FAcE (Formulated Alhydrogel competitive ELISA) method for direct quantification of OAg present in Shigella sonnei GMMA-based vaccine and its optimization using Design of Experiments approach. Necchi F; Carducci M; Pisoni I; Rossi O; Saul A; Rondini S J Immunol Methods; 2019 Aug; 471():11-17. PubMed ID: 31039338 [TBL] [Abstract][Full Text] [Related]
6. Dissecting the contribution of O-Antigen and proteins to the immunogenicity of Shigella sonnei generalized modules for membrane antigens (GMMA). Mancini F; Gasperini G; Rossi O; Aruta MG; Raso MM; Alfini R; Biagini M; Necchi F; Micoli F Sci Rep; 2021 Jan; 11(1):906. PubMed ID: 33441861 [TBL] [Abstract][Full Text] [Related]
7. Production of a Shigella sonnei Vaccine Based on Generalized Modules for Membrane Antigens (GMMA), 1790GAHB. Gerke C; Colucci AM; Giannelli C; Sanzone S; Vitali CG; Sollai L; Rossi O; Martin LB; Auerbach J; Di Cioccio V; Saul A PLoS One; 2015; 10(8):e0134478. PubMed ID: 26248044 [TBL] [Abstract][Full Text] [Related]
8. Development, Interlaboratory Evaluations, and Application of a Simple, High-Throughput Nahm MH; Yu J; Weerts HP; Wenzel H; Tamilselvi CS; Chandrasekaran L; Pasetti MF; Mani S; Kaminski RW mSphere; 2018 Jun; 3(3):. PubMed ID: 29898979 [No Abstract] [Full Text] [Related]
9. A Phase 2a Randomized Study to Evaluate the Safety and Immunogenicity of the 1790GAHB Generalized Modules for Membrane Antigen Vaccine against Obiero CW; Ndiaye AGW; Sciré AS; Kaunyangi BM; Marchetti E; Gone AM; Schütte LD; Riccucci D; Auerbach J; Saul A; Martin LB; Bejon P; Njuguna P; Podda A Front Immunol; 2017; 8():1884. PubMed ID: 29375556 [TBL] [Abstract][Full Text] [Related]
10. Exploring the Role of GMMA Components in the Immunogenicity of a 4-Valent Vaccine against Mancini F; Alfini R; Caradonna V; Monaci V; Carducci M; Gasperini G; Piccioli D; Biagini M; Giannelli C; Rossi O; Pizza M; Micoli F Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769063 [TBL] [Abstract][Full Text] [Related]
11. Efficacy, safety, and immunogenicity of the Frenck RW; Conti V; Ferruzzi P; Ndiaye AGW; Parker S; McNeal MM; Dickey M; Granada JP; Cilio GL; De Ryck I; Necchi F; Suvarnapunya AE; Rossi O; Acquaviva A; Chandrasekaran L; Clarkson KA; Auerbach J; Marchetti E; Kaminski RW; Micoli F; Rappuoli R; Saul A; Martin LB; Podda A EClinicalMedicine; 2021 Sep; 39():101076. PubMed ID: 34430837 [TBL] [Abstract][Full Text] [Related]
12. Detection of antibodies to Shigella lipopolysaccharide in urine after natural Shigella infection or vaccination. Cohen D; Orr N; Robin G; Slepon R; Ashkenazi S; Ashkenazi I; Shemer J Clin Diagn Lab Immunol; 1996 Jul; 3(4):451-5. PubMed ID: 8807212 [TBL] [Abstract][Full Text] [Related]
16. GMMA Technology for the Development of Safe Vaccines: Meta-Analysis of Individual Patient Data to Assess the Safety Profile of Shigella sonnei 1790GAHB Vaccine in Healthy Adults, with Special Focus on Neutropenia. De Ryck I; Sarakinou E; Nakakana U; Cilio GL; Ndiaye A; Vella V; Auerbach J; Granada JP; Conti V; Podda A Infect Dis Ther; 2022 Apr; 11(2):757-770. PubMed ID: 35118580 [TBL] [Abstract][Full Text] [Related]
17. A phase I trial of WRSS1, a Raqib R; Sarker P; Zaman K; Alam NH; Wierzba TF; Maier N; Talukder K; Baqui AH; Suvarnapunya AE; Qadri F; Walker RI; Fix A; Venkatesan MM Hum Vaccin Immunother; 2019; 15(6):1326-1337. PubMed ID: 30794051 [No Abstract] [Full Text] [Related]
18. Quantitative analysis of IgG class and subclass and IgA serum response to Shigella sonnei and Shigella flexneri 2a polysaccharides following vaccination with Shigella conjugate vaccines. Robin G; Keisari Y; Slepon R; Ashkenazi S; Cohen D Vaccine; 1999 Aug; 17(23-24):3109-15. PubMed ID: 10462247 [TBL] [Abstract][Full Text] [Related]